Owner Biovitrum AB Amgen Inc

Inventors Hendriksson, Martin; Homan, Evert; Johansson, Lars; Vallgarda, Jerk; Williams, Meredith; Bercot, Eric A.; Fotsch, Christopher H.; Li, Aiwen; Cai, Guolin; Hungate, Randall W.; Yuan, Chester Chenguang; Tegley, Christopher; St. Jean Jr., David J.

Agent Knightsbridge Patent Attorneys

Pub. Number AU-A-2012204095

Parent 2006316867

Filing date 6 July 2012

Wipo publication date 9 August 2012

C07D 277/54 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 - 1,3-Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/428 - condensed with carbocyclic rings

A61P 3/04 Drugs for disorders of the metabolism

A61P 3/06 Drugs for disorders of the metabolism

A61P 3/10 Drugs for disorders of the metabolism

A61P 9/12 Drugs for disorders of the cardiovascular system

A61P 19/10 Drugs for skeletal disorders

A61P 25/24 Drugs for disorders of the nervous system

C07D 277/60 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group